Cornelus F van Nostrum
Overview
Explore the profile of Cornelus F van Nostrum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poortinga A, van Nostrum C
Int J Pharm
. 2025 Feb;
672:125309.
PMID: 39904478
In this work we present a new encapsulation method that allows for the controlled release of drugs under simulated small intestinal conditions. This method consists of encapsulation within microbubbles and...
2.
Aziz B, Bosman E, van der Wurff-Jacobs K, van Nostrum C, Khurshid A
Biomed Mater
. 2025 Jan;
20(2).
PMID: 39879653
extract (FCe) is a natural herb that has received a lot of interest in cancer treatment due to its potential anticancer activities against various malignancies. However, due to FCe's low...
3.
Mesquita B, Singh A, Prats Masdeu C, Lokhorst N, Hebels E, van Steenbergen M, et al.
Int J Pharm
. 2024 Mar;
655:124004.
PMID: 38492899
Photodynamic therapy (PDT) is a suitable alternative to currently employed cancer treatments. However, the hydrophobicity of most photosensitizers (e.g., zinc phthalocyanine (ZnPC)) leads to their aggregation in blood. Moreover, non-specific...
4.
Nottelet B, Buwalda S, van Nostrum C, Zhao X, Deng C, Zhong Z, et al.
JPhys Mater
. 2023 Dec;
7(1):012502.
PMID: 38144214
This Roadmap on drug delivery aims to cover some of the most recent advances in the field of materials for drug delivery systems (DDSs) and emphasizes the role that multifunctional...
5.
Zia R, Poortinga A, Nazir A, AbuRuz S, van Nostrum C
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140097
Developing carriers capable of efficiently transporting both hydrophilic and lipophilic payloads is a captivating focus within the pharmaceutical and drug delivery research domain. Antibubbles, constituting an innovative encapsulation system designed...
6.
Atlas N, Uzair B, Movellan J, Gracia R, Dupin D, Loinaz I, et al.
Heliyon
. 2023 Dec;
9(12):e22821.
PMID: 38125473
are bacteria associated with respiratory tract infections and are increasingly becoming resistant to antibiotics, including carbapenems. Apramycin is a veterinary antibiotic that may have the potential to be re-purposed for...
7.
Neumann M, di Marco G, Iudin D, Viola M, van Nostrum C, van Ravensteijn B, et al.
Macromolecules
. 2023 Nov;
56(21):8377-8392.
PMID: 38024154
In the past decade, stimuli-responsive hydrogels are increasingly studied as biomaterials for tissue engineering and regenerative medicine purposes. Smart hydrogels can not only replicate the physicochemical properties of the extracellular...
8.
Zia R, Poortinga A, Nazir A, Ayyash M, van Nostrum C
J Colloid Interface Sci
. 2023 Sep;
652(Pt B):2054-2065.
PMID: 37696059
Hypothesis: Hydrophobized fumed silica particles were previously reported for producing antibubbles that are quite stable in neutral as well as in acidic media. To produce acid-responsive antibubbles (e.g., for gastric...
9.
Liu M, Lau C, Cabello I, Garssen J, Willemsen L, Hennink W, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(6).
PMID: 37375766
Our previous study demonstrated that a selected β-lactoglobulin-derived peptide (BLG-Pep) loaded in poly(lactic--glycolic acid) (PLGA) nanoparticles protected mice against cow's milk allergy development. However, the mechanism(s) responsible for the interaction...
10.
Liu M, Thijssen S, Hennink W, Garssen J, van Nostrum C, Willemsen L
Front Immunol
. 2023 Jan;
13:1053107.
PMID: 36703973
Cow's milk allergy is a common food allergy among infants. Improved hygiene conditions and loss of microbial diversity are associated with increased risk of allergy development. The intestinal immune system...